Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL OFFICE-BASED LABS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL OFFICE-BASED LABS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL OFFICE-BASED LABS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 INDUSTRY INSIGHTS
7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
7.1 PRICE IMPACT
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 GLOBAL OFFICE-BASED LABS MARKET, BY TYPE
8.1 OVERVIEW
8.2 IMAGING SYSTEM
8.2.1 C-ARMS
8.2.2 ULTRASOUND
8.2.3 OTHERS
8.3 DEVICES
8.3.1 IVUS
8.3.2 ATHERECTOMY
8.3.2.1. MECHANICAL
8.3.2.2. LASER
8.3.3 SPECIALTY BALLOONS
8.3.4 IFR/FFR
8.3.5 OTHERS
8.4 EQUIPMENT
8.4.1 PATIENT MONITORING
8.4.2 POWER INJECTORS
8.4.3 TABLES
8.4.4 CATH LABS STANDS
8.4.5 CARTS
8.4.6 OTHERS
8.5 OTHERS
9 GLOBAL OFFICE-BASED LABS MARKET, BY MODALITY
9.1 OVERVIEW
9.2 SINGLE SPECIALTY LABS
9.3 MULTI-SPECIALTY LABS
9.4 HYBRID LABS
10 GLOBAL OFFICE-BASED LABS MARKET, BY SERVICE
10.1 OVERVIEW
10.2 PERIPHERAL VASCULAR INTERVENTION
10.2.1 SINGLE SPECIALTY LABS
10.2.2 MULTI-SPECIALTY LABS
10.2.3 HYBRID LABS
10.3 ENDOVASCULAR INTERVENTIONS
10.3.1 SINGLE SPECIALTY LABS
10.3.2 MULTI-SPECIALTY LABS
10.3.3 HYBRID LABS
10.4 CARDIAC
10.4.1 SINGLE SPECIALTY LABS
10.4.2 MULTI-SPECIALTY LABS
10.4.3 HYBRID LABS
10.5 INTERVENTIONAL RADIOLOGY
10.5.1 SINGLE SPECIALTY LABS
10.5.2 MULTI-SPECIALTY LABS
10.5.3 HYBRID LABS
10.6 VENOUS
10.6.1 SINGLE SPECIALTY LABS
10.6.2 MULTI-SPECIALTY LABS
10.6.3 HYBRID LABS
10.7 OTHERS
11 GLOBAL OFFICE-BASED LABS MARKET, BY SPECIALIST
11.1 OVERVIEW
11.2 VASCULAR SURGEONS
11.3 INTERVENTIONAL CARDIOLOGISTS
11.4 INTERVENTIONAL RADIOLOGISTS
11.5 OTHERS
12 GLOBAL OFFICE-BASED LABS MARKET, BY PROCEDURE
12.1 OVERVIEW
12.2 DIAGNOSTIC IMAGING (INCLUDING CARDIAC)
12.3 ANGIOPLASTY AND STENTING
12.4 ATHERECTOMY
12.5 THROMBECTOMY
12.6 EMBOLIZATION (UTERINE ARTERY EMBOLIZATION)
12.7 IVUS
12.8 DIALYSIS ACCESS DECLOTS
12.9 IVC FILTER PLACEMENT AND REMOVAL
12.1 VENOUS ABLATION
12.11 CENTRAL VENOUS INTERVENTIONS
12.12 DVT INTERVENTIONS
12.13 OTHERS
13 GLOBAL OFFICE-BASED LABS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTORS
14 GLOBAL OFFICE-BASED LABS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS:ASIA-PACIFIC
14.5 MERGERS & ACQUISITIONS
14.6 NEW PRODUCT DEVELOPMENT & APPROVALS
14.7 EXPANSIONS
14.8 REGULATORY CHANGES
14.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
15 GLOBAL OFFICE-BASED LABS MARKET, BY GEOGRAPHY
15.1 GLOBAL OFFICE-BASED LABS MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
15.1.1 NORTH AMERICA
15.1.1.1. U.S.
15.1.1.2. CANADA
15.1.1.3. MEXICO
15.1.2 EUROPE
15.1.2.1. GERMANY
15.1.2.2. FRANCE
15.1.2.3. U.K.
15.1.2.4. ITALY
15.1.2.5. SPAIN
15.1.2.6. RUSSIA
15.1.2.7. TURKEY
15.1.2.8. BELGIUM
15.1.2.9. NETHERLANDS
15.1.2.10. SWITZERLAND
15.1.2.11. REST OF EUROPE
15.1.3 ASIA-PACIFIC
15.1.3.1. JAPAN
15.1.3.2. CHINA
15.1.3.3. SOUTH KOREA
15.1.3.4. INDIA
15.1.3.5. AUSTRALIA
15.1.3.6. SINGAPORE
15.1.3.7. THAILAND
15.1.3.8. MALAYSIA
15.1.3.9. INDONESIA
15.1.3.10. PHILIPPINES
15.1.3.11. REST OF ASIA-PACIFIC
15.1.4 SOUTH AMERICA
15.1.4.1. BRAZIL
15.1.4.2. ARGENTINA
15.1.4.3. REST OF SOUTH AMERICA
15.1.5 MIDDLE EAST AND AFRICA
15.1.5.1. SOUTH AFRICA
15.1.5.2. SAUDI ARABIA
15.1.5.3. UAE
15.1.5.4. EGYPT
15.1.5.5. ISRAEL
15.1.5.6. REST OF MIDDLE EAST AND AFRICA
15.1.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
16 GLOBAL OFFICE-BASED LABS MARKET, SWOT AND DBMR ANALYSIS
17 GLOBAL OFFICE-BASED LABS MARKET, COMPANY PROFILE
17.1 MEDTRONIC
17.1.1 COMPANY OVERVIEW
17.1.2 REVENUE ANALYSIS
17.1.3 GEOGRAPHIC PRESENCE
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 CASSLING (A PARTNER SIEMENS HEALTHINEERS)
17.2.1 COMPANY OVERVIEW
17.2.2 REVENUE ANALYSIS
17.2.3 GEOGRAPHIC PRESENCE
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 ZIEHM IMAGING GMBH
17.3.1 COMPANY OVERVIEW
17.3.2 REVENUE ANALYSIS
17.3.3 GEOGRAPHIC PRESENCE
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 BOSTON SCIENTIFIC CORPORATION
17.4.1 COMPANY OVERVIEW
17.4.2 REVENUE ANALYSIS
17.4.3 GEOGRAPHIC PRESENCE
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 KONINKLIJKE PHILIPS N.V.
17.5.1 COMPANY OVERVIEW
17.5.2 REVENUE ANALYSIS
17.5.3 GEOGRAPHIC PRESENCE
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 GE HEALTHCARE (A PART OF GENERAL ELECTRIC COMPANY)
17.6.1 COMPANY OVERVIEW
17.6.2 REVENUE ANALYSIS
17.6.3 GEOGRAPHIC PRESENCE
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENTS
17.7 ABBOTT
17.7.1 COMPANY OVERVIEW
17.7.2 REVENUE ANALYSIS
17.7.3 GEOGRAPHIC PRESENCE
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENTS
17.8 CSI (CARDIOVASCULAR SYSTEMS, INC.)
17.8.1 COMPANY OVERVIEW
17.8.2 REVENUE ANALYSIS
17.8.3 GEOGRAPHIC PRESENCE
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENTS
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
18 RELATED REPORTS
19 QUESTIONNAIRE
20 ABOUT DATA BRIDGE MARKET RESEARCH
